NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 85 filers reported holding NEURODERM LTD in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,228,000 | -43.0% | 74,500 | -57.7% | 0.38% | -61.7% |
| Q4 2016 | $3,906,000 | -16.7% | 175,951 | -30.6% | 0.99% | +29.6% |
| Q3 2016 | $4,687,000 | +11.6% | 253,513 | -1.9% | 0.76% | -30.1% |
| Q2 2016 | $4,201,000 | +78.8% | 258,513 | +55.4% | 1.09% | +114.3% |
| Q1 2016 | $2,349,000 | +33.7% | 166,359 | +95.7% | 0.51% | +127.2% |
| Q3 2015 | $1,757,000 | – | 85,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERTEX ONE ASSET MANAGEMENT INC. | 29,200 | $1,134,000 | 0.19% |
| Opera Trading Capital | 3,611 | $141,000 | 0.03% |
| IFP Advisors, Inc | 600 | $23,000 | 0.00% |
| Ancora Advisors LLC | 10,000 | $0 | 0.00% |
| Focused Wealth Management, Inc | 32 | $1,000 | 0.00% |